Germany: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Germany

The German prophylactic medicaments containing insulin market reduced slightly to $X in 2022, remaining constant against the previous year. The market value increased at an average annual rate of +1.9% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, the market attained the maximum level at $X in 2014; however, from 2015 to 2022, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Germany

In value terms, prophylactic medicaments containing insulin production contracted to $X in 2022 estimated in export price. Overall, the total production indicated modest growth from 2012 to 2022: its value increased at an average annual rate of +1.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by +0.5% against 2020 indices. The pace of growth was the most pronounced in 2013 with an increase of 38% against the previous year. Prophylactic medicaments containing insulin production peaked at $X in 2014; however, from 2015 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Germany

In 2022, prophylactic medicaments containing insulin exports from Germany dropped to X tons, falling by -2.8% on 2021. Overall, exports, however, recorded a relatively flat trend pattern. The pace of growth was the most pronounced in 2013 when exports increased by 13% against the previous year. The exports peaked at X tons in 2014; however, from 2015 to 2022, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports dropped to $X in 2022. Over the period under review, exports showed a perceptible descent. The growth pace was the most rapid in 2013 with an increase of 36% against the previous year. Over the period under review, the exports hit record highs at $X in 2014; however, from 2015 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

The United States (X tons) was the main destination for prophylactic medicaments containing insulin exports from Germany, accounting for a 18% share of total exports. Moreover, prophylactic medicaments containing insulin exports to the United States exceeded the volume sent to the second major destination, the United Arab Emirates (X tons), threefold. The third position in this ranking was held by Poland (X tons), with a 6.6% share.

From 2012 to 2022, the average annual growth rate of volume to the United States stood at -2.6%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United Arab Emirates (-2.3% per year) and Poland (+3.2% per year).

In value terms, the United States ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Germany, comprising 36% of total exports. The second position in the ranking was held by Algeria ($X), with a 5.5% share of total exports. It was followed by Hungary, with a 4.9% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the United States totaled -9.7%. Exports to the other major destinations recorded the following average annual rates of exports growth: Algeria (+195.0% per year) and Hungary (+3.6% per year).

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per kg, dropping by -9.3% against the previous year. Overall, the export price showed a deep slump. The most prominent rate of growth was recorded in 2013 when the average export price increased by 20%. The export price peaked at $X per kg in 2014; however, from 2015 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Spain ($X per kg), while the average price for exports to Romania ($X per kg) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Italy (+7.3%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Germany

Prophylactic medicaments containing insulin imports into Germany dropped to X tons in 2022, which is down by -2.8% on 2021. Overall, imports showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2019 with an increase of 14%. As a result, imports attained the peak of X tons. From 2020 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports contracted to $X in 2022. Over the period under review, imports saw a perceptible decrease. The most prominent rate of growth was recorded in 2019 with an increase of 21%. Over the period under review, imports attained the maximum at $X in 2020; however, from 2021 to 2022, imports failed to regain momentum.

Imports by Country

France (X tons), Denmark (X tons) and Italy (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Germany, together accounting for 95% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Denmark (with a CAGR of +4.1%), while imports for the other leaders experienced a decline.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Germany were Denmark ($X), France ($X) and Italy ($X), together accounting for 95% of total imports.

Denmark, with a CAGR of +5.1%, recorded the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced a decline.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, which is down by -11.2% against the previous year. Over the period under review, the import price continues to indicate a mild setback. The most prominent rate of growth was recorded in 2020 when the average import price increased by 10% against the previous year. Over the period under review, average import prices hit record highs at $X per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for France ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (+1.0%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :